{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "JPY", "esgPopulated": false, "market": "jp_market", "longName": "MediciNova, Inc.", "marketState": "CLOSED", "regularMarketPrice": 300.0, "messageBoardId": "finmb_9262264", "exchange": "JPX", "shortName": "MEDICINOVA INC", "exchangeTimezoneShortName": "JST", "exchangeTimezoneName": "Asia/Tokyo", "regularMarketChangePercent": 1.010101, "gmtOffSetMilliseconds": 32400000, "fiftyTwoWeekLowChange": 18.0, "fiftyTwoWeekLowChangePercent": 0.06382979, "fiftyTwoWeekRange": "282.0 - 399.0", "fiftyTwoWeekHighChange": -99.0, "fiftyTwoWeekHighChangePercent": -0.24812031, "fiftyTwoWeekLow": 282.0, "fiftyTwoWeekHigh": 399.0, "earningsTimestamp": 1676581200, "earningsTimestampStart": 1691611200, "earningsTimestampEnd": 1692043200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -38.16, "epsForward": -0.51, "epsCurrentYear": -0.28, "firstTradeDateMilliseconds": 1198801800000, "priceHint": 2, "regularMarketChange": 3.0, "regularMarketTime": 1683872100, "regularMarketDayHigh": 303.0, "regularMarketDayRange": "296.0 - 303.0", "regularMarketDayLow": 296.0, "regularMarketVolume": 42200, "regularMarketPreviousClose": 297.0, "bid": 299.0, "ask": 302.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Tokyo", "financialCurrency": "USD", "regularMarketOpen": 303.0, "averageDailyVolume3Month": 58368, "averageDailyVolume10Day": 78657, "priceEpsCurrentYear": -1071.4286, "sharesOutstanding": 49046200, "bookValue": 1.432, "fiftyDayAverage": 296.48, "fiftyDayAverageChange": 3.519989, "fiftyDayAverageChangePercent": 0.011872602, "twoHundredDayAverage": 311.285, "twoHundredDayAverageChange": -11.285004, "twoHundredDayAverageChangePercent": -0.036252964, "marketCap": 14799540224, "forwardPE": -588.2353, "priceToBook": 209.49721, "sourceInterval": 15, "exchangeDataDelayedBy": 20, "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "symbol": "4875.T"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "4275 Executive Square", "address2": "Suite 300", "city": "La Jolla", "state": "CA", "zip": "92037", "country": "United States", "phone": "858 373 1500", "fax": "858 404 0048", "website": "https://www.medicinova.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological and other disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. The company's product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic and other diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. It has collaboration agreements with Kissei Pharmaceutical Co., Ltd.; Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. The company was incorporated in 2000 and is headquartered in La Jolla, California.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Dr. Yuichi  Iwaki M.D., Ph.D.", "age": 72, "title": "Co-Founder, Pres, CEO & Exec. Director", "yearBorn": 1950, "fiscalYear": 2022, "totalPay": {"raw": 933046, "fmt": "933.05k", "longFmt": "933,046"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Kazuko  Matsuda M.D., M.P.H., MPH, Ph.D.", "age": 56, "title": "Chief Medical Officer & Director", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": {"raw": 653654, "fmt": "653.65k", "longFmt": "653,654"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jason J. Kruger CPA", "age": 45, "title": "CFO & Principal Financial Officer", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. David H. Crean M.B.A., Ph.D.", "age": 57, "title": "Chief Bus. Officer", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John  O'Neil CPA", "title": "Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 5, "overallRisk": 8, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}